Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)-Reference-Cited by-同舟云学术

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)

Published:2021-01 Issue:1 Volume:40 Page:286-294
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Cho Sung Yong¹^ORCID,Jeong Seong Jin²^ORCID,Lee Sangchul²^ORCID,Kim Janghwan³^ORCID,Lee Seong Ho⁴^ORCID,Choo Min Soo⁵^ORCID,Oh Seung‐June¹^ORCID

Affiliation:

1. Department of Urology Seoul National University College of Medicine, Seoul National University Hospital Seoul South Korea

2. Department of Urology Seoul National University Bundang Hospital Seongnam‐si Gyeonggi‐do South Korea

3. Department of Urology and Urological Science Institute, Severance Hospital Yonsei University College of Medicine Seoul South Korea

4. Department of Urology, College of Medicine Dongtan Sacred Heart Hospital, Hallym University Hwaseong South Korea

5. Seoul Metropolitan Government‐Seoul National University Boramae Medical Center Seoul South Korea

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24552

Reference20 articles.

1. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus;Winge K;Mov Disord,2007

2. Urinary dysfunction in early and untreated Parkinson's disease;Uchiyama T;J Neurol Neurosurg Psychiatry,2011

3. The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease

4. Bladder dysfunction in Parkinsonism: Mechanisms, prevalence, symptoms, and management

5. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials;Frontiers in Surgery;2024-08-26

2. Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches;Molecular Neurobiology;2024-08-05

3. Efficacy of medication for overactive bladder symptoms in 70 patients with Parkinson’s disease;Translational Andrology and Urology;2024-01

4. Safety and efficacy of beta-3 adrenergic agonists in treating neurogenic lower urinary tract dysfunction: A systematic review and meta-analysis;Investigative and Clinical Urology;2024

5. Medical, surgical, and physical treatments for Parkinson's disease;The Lancet;2024-01